Skip to main content
main-content

Small cell lung cancer

Journal articles and book chapters

13-09-2019 | Small-cell lung cancer | Video | Article

Expert comment: CASPIAN trial of durvalumab in SCLC

WATCH | Raffaele Califano comments on the CASPIAN trial of front-line durvalumab plus chemotherapy in extensive-stage small-cell lung cancer, and puts the findings in context of the IMpower133 study of atezolizumab in the same setting (3:30).

08-09-2019 | Lung cancer | Video | Article

Expert highlights from WCLC 2019

WATCH | Advisory Board member Ross Camidge shares his top picks of the presentations at the 2019 World Conference on Lung Cancer, including the CASPIAN trial and the updated AMG 510 data (1:51).

17-06-2019 | Small-cell lung cancer | Article

Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential

Armstrong SA & Liu SV. Adv Ther 2019. doi:10.1007/s12325-019-01008-2

08-04-2017 | Small-cell lung cancer | Article

Optimal radiation therapy for small cell lung cancer

Gensheimer MF, Loo BW. Curr Treat Options in Oncol 2017; 18: 21. doi:10.1007/s11864-017-0467-z

28-03-2017 | Small-cell lung cancer | Article

Impact of radiation therapy in surgically resected limited-stage small cell lung carcinoma

Kim SK et al. Lung 2017. doi:10.1007/s00408-017-9992-6

02-03-2017 | Liquid biopsy | Review | Article

Integrating liquid biopsies into the management of cancer

Nat Rev Clin Oncol 2017; 14: 531–548. doi: 10.1038/nrclinonc.2017.14

24-02-2017 | Liquid biopsy | Review | Article

Liquid biopsies come of age: Towards implementation of circulating tumor DNA

Nat Rev Cancer 2017; 17: 223–238. doi: 10.1038/nrc.2017.7

28-01-2017 | Small-cell lung cancer | Article

Small cell lung cancer and molecular targeted therapy

Iwasaw S. In: Molecular Targeted Therapy of Lung Cancer. Edited by Takiguchi Y. Springer Science+Business Media Singapore 2017. doi:10.1007/978-981-10-2002-5_8

28-09-2016 | Small-cell lung cancer | Article

FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid

Kang et al. demonstrate that immunohistochemical detection of FAIM2 expression outperforms the known neuroendocrine tumor marker synaptophysin in small cell lung cancers and atypical carcinoids.

Scientific Reports 2016;6:34022. doi:10.1038/srep34022

18-08-2016 | Small-cell lung cancer | Article

Small cell lung cancer

Bernhardt EB, Jalal SI. In: Lung Cancer. Edited by Reckamp KL. Springer International Publishing Switzerland 2016. doi:10.1007/978-3-319-40389-2_14

18-12-2015 | Small-cell lung cancer | Article

The role of 18F-FDG PET/CT on staging and prognosis in patients with small cell lung cancer

Domachevsky et al. examine how positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography improves the staging and prognosis of patients with small cell lung cancer.

Zer A. et al. Eur Radiol 2016; 26: 3155. doi:10.1007/s00330-015-4132-2

15-10-2015 | Small-cell lung cancer | Article

The role of radiotherapy in the treatment of small-cell lung cancer

Nosaki K, Seto T. Curr Treat Options in Oncol 2015; 16: 56. doi:10.1007/s11864-015-0372-2

Image Credits